Integragen (ALINT)
EU
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
The current ALINT market cap is 3.7M. The company's latest EPS is EUR -0.0260 and P/E is -21.54.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 8.32M | 9.15M | 11.46M | 13.38M | 12.83M |
| Operating Income | -326k | -256k | -44k | -85k | -119k |
| Net Income | -285k | -375k | 15k | -4k | -172k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 6.75M | 8.82M | 9.6M | 9.02M | 8M |
| Total Liabilities | 4.24M | 6.65M | 7.42M | 6.84M | 5.99M |
| Total Equity | 2.51M | 2.17M | 2.19M | 2.18M | 2.01M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | N/A | N/A | N/A | N/A | N/A |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | N/A | N/A | N/A | N/A | N/A |
| Market Cap | 3.7M |
| Price to Earnings Ratio | -21.54 |
| Price to Sales Ratio | 0.29 |
| Price to Cash Ratio | 2.02 |
| Price to Book Ratio | 1.84 |
| Dividend Yield | - |
| Shares Outstanding | 6.6M |
| Average Volume (1 week) | 471 |
| Average Volume (1 Month) | 744 |
| 52 Week Change | -61.38% |
| 52 Week High | 1.50 |
| 52 Week Low | 0.53 |
| Spread (Intraday) | 0.04 (6.9%) |
| Company Name | Integragen |
| Address |
genopole campus 1 - batiment 8 evry, essonne 91000 |
| Website | https://www.integragen.fr |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
